Skip to content

Clinical trials

Neuromyelitis Optica trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neuromyelitis Optica Country / region: Canada Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20111
20141
20152
20191
20201
20211
20221
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Recruiting2
Terminated2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Alexion Pharmaceuticals, Inc.5
Hoffmann-La Roche2
Amgen1
MedImmune LLC1
Novartis Pharmaceuticals1
University of Calgary1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neuromyelitis Optica11
Demyelinating Diseases5
Myelitis, Transverse3
Optic Neuritis3
Recurrence3
Diffuse Cerebral Sclerosis of Schilder1
Multiple Sclerosis1
Multiple Sclerosis, Relapsing-Remitting1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.